treatment options for patients with dlbcl who relapse after car-t therapy
Published 1 year ago • 597 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
5:24
treatment strategies for patients with dlbcl who relapse after car-t therapy
-
1:55
treatment options for dlbcl patients who relapse after car-t cell therapy
-
0:44
emerging options for patients with dlbcl who relapse after car-t therapy
-
0:32
enhancing outcomes of patients with dlbcl treated with car t-cell therapy
-
6:54
the future of car-t therapy in the management of dlbcl
-
2:10
new algorithm for second-line dlbcl: the role of car-t therapy
-
1:04
bispecifics & car-t therapy in dlbcl: sequencing and selecting between these agents
-
1:20
limitations of car t-cell therapy for dlbcl
-
1:31
car-t therapy versus autosct in dlbcl
-
3:52
updates on the use of car-t therapy for the treatment of dlbcl in the second-line setting
-
2:05
strategies to implement car-t in dlbcl
-
2:52
comparing the efficacy and curative potential of car-t therapy & bispecific antibodies in r/r dlbcl
-
2:42
clinical indications for car-t therapy in dlbcl & the possibility of moving car-t into earlier lines
-
3:12
the role of car t-cell therapy in dlbcl
-
2:38
weighing up the pros and cons of car-t therapy and bispecific antibodies in r/r dlbcl
-
2:25
healthcare decision-making in patients with dlbcl treated with car-t vs. non-car-t therapies
-
2:10
optimizing car-t therapy in lbcl
-
3:05
car-t therapy in r/r dlbcl
-
1:01
impact of specific comorbidities on the outcome of patients with dlbcl treated with car-t therapy